List of Excipients in API lumacaftor and ivacaftor
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing lumacaftor and ivacaftor
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | ORKAMBI | lumacaftor and ivacaftor | 51167-809 | AMMONIA | 2031-06-11 |
| Vertex Pharmaceuticals Incorporated | ORKAMBI | lumacaftor and ivacaftor | 51167-809 | CARMINIC ACID | 2031-06-11 |
| Vertex Pharmaceuticals Incorporated | ORKAMBI | lumacaftor and ivacaftor | 51167-809 | CELLULOSE, MICROCRYSTALLINE | 2031-06-11 |
| Vertex Pharmaceuticals Incorporated | ORKAMBI | lumacaftor and ivacaftor | 51167-809 | CROSCARMELLOSE SODIUM | 2031-06-11 |
| Vertex Pharmaceuticals Incorporated | ORKAMBI | lumacaftor and ivacaftor | 51167-809 | FD&C BLUE NO. 1 | 2031-06-11 |
| Vertex Pharmaceuticals Incorporated | ORKAMBI | lumacaftor and ivacaftor | 51167-809 | FD&C BLUE NO. 2 | 2031-06-11 |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for lumacaftor and ivacaftor
Excipient focus: AMMONIA
lumacaftor and ivacaftor drug variants containing AMMONIA
| Company | Ingredient | NDC |
|---|---|---|
| Vertex Pharmaceuticals Incorporated | lumacaftor and ivacaftor | 51167-809 |
| >Company | >Ingredient | >NDC |
lumacaftor and ivacaftor drug variants not containing AMMONIA
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CARMINIC ACID
lumacaftor and ivacaftor drug variants containing CARMINIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Vertex Pharmaceuticals Incorporated | lumacaftor and ivacaftor | 51167-809 |
| >Company | >Ingredient | >NDC |
lumacaftor and ivacaftor drug variants not containing CARMINIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
lumacaftor and ivacaftor drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Vertex Pharmaceuticals Incorporated | lumacaftor and ivacaftor | 51167-809 |
| >Company | >Ingredient | >NDC |
lumacaftor and ivacaftor drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
lumacaftor and ivacaftor drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Vertex Pharmaceuticals Incorporated | lumacaftor and ivacaftor | 51167-809 |
| >Company | >Ingredient | >NDC |
lumacaftor and ivacaftor drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 1
lumacaftor and ivacaftor drug variants containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| Vertex Pharmaceuticals Incorporated | lumacaftor and ivacaftor | 51167-809 |
| >Company | >Ingredient | >NDC |
lumacaftor and ivacaftor drug variants not containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 2
lumacaftor and ivacaftor drug variants containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| Vertex Pharmaceuticals Incorporated | lumacaftor and ivacaftor | 51167-809 |
| >Company | >Ingredient | >NDC |
lumacaftor and ivacaftor drug variants not containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
lumacaftor and ivacaftor drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Vertex Pharmaceuticals Incorporated | lumacaftor and ivacaftor | 51167-809 |
| >Company | >Ingredient | >NDC |
lumacaftor and ivacaftor drug variants not containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE ACETATE SUCCINATE 06081224
lumacaftor and ivacaftor drug variants containing HYPROMELLOSE ACETATE SUCCINATE 06081224
| Company | Ingredient | NDC |
|---|---|---|
| Vertex Pharmaceuticals Incorporated | lumacaftor and ivacaftor | 51167-809 |
| >Company | >Ingredient | >NDC |
lumacaftor and ivacaftor drug variants not containing HYPROMELLOSE ACETATE SUCCINATE 06081224
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
lumacaftor and ivacaftor drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Vertex Pharmaceuticals Incorporated | lumacaftor and ivacaftor | 51167-809 |
| >Company | >Ingredient | >NDC |
lumacaftor and ivacaftor drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 3350
lumacaftor and ivacaftor drug variants containing POLYETHYLENE GLYCOL 3350
| Company | Ingredient | NDC |
|---|---|---|
| Vertex Pharmaceuticals Incorporated | lumacaftor and ivacaftor | 51167-809 |
| >Company | >Ingredient | >NDC |
lumacaftor and ivacaftor drug variants not containing POLYETHYLENE GLYCOL 3350
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYVINYL ALCOHOL
lumacaftor and ivacaftor drug variants containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Vertex Pharmaceuticals Incorporated | lumacaftor and ivacaftor | 51167-809 |
| >Company | >Ingredient | >NDC |
lumacaftor and ivacaftor drug variants not containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
lumacaftor and ivacaftor drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Vertex Pharmaceuticals Incorporated | lumacaftor and ivacaftor | 51167-809 |
| >Company | >Ingredient | >NDC |
lumacaftor and ivacaftor drug variants not containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
lumacaftor and ivacaftor drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Vertex Pharmaceuticals Incorporated | lumacaftor and ivacaftor | 51167-809 |
| >Company | >Ingredient | >NDC |
lumacaftor and ivacaftor drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SHELLAC
lumacaftor and ivacaftor drug variants containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| Vertex Pharmaceuticals Incorporated | lumacaftor and ivacaftor | 51167-809 |
| >Company | >Ingredient | >NDC |
lumacaftor and ivacaftor drug variants not containing SHELLAC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
lumacaftor and ivacaftor drug variants containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Vertex Pharmaceuticals Incorporated | lumacaftor and ivacaftor | 51167-809 |
| >Company | >Ingredient | >NDC |
lumacaftor and ivacaftor drug variants not containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
lumacaftor and ivacaftor drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Vertex Pharmaceuticals Incorporated | lumacaftor and ivacaftor | 51167-809 |
| >Company | >Ingredient | >NDC |
lumacaftor and ivacaftor drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
lumacaftor and ivacaftor drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Vertex Pharmaceuticals Incorporated | lumacaftor and ivacaftor | 51167-809 |
| >Company | >Ingredient | >NDC |
lumacaftor and ivacaftor drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
